Fortrea vs Guardant Health
FTRE and GH side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FTRE and GH compare
Guardant Health is the larger company, worth 11 times as much as Fortrea ($20.8B against $2.0B).
Guardant Health grew revenue faster over the last twelve months (41.7% versus −3.4% for Fortrea).
Fortrea keeps more of each dollar of sales as profit, with a net margin of −2.6% compared with −37.9% at Guardant Health.
Guardant Health scores higher on the StockData Score (9 against 4 for Fortrea), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FTRE | GH |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $20.8B |
| Share price | $20.38 | $154.78 |
| Change, 1 year | 82.3% | 58.1% |
| Change, 5 years | – | 58.6% |
| Beta (5Y) | 1.47 | 1.62 |
| Employees | 14K | 2,506 |
| StockData Score | ||
| Total score | 4 | 9 (better) |
| Valuation score | 0 | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 (better) | 1 |
| Health score | 0 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.7× (better) | 16.2× |
| P/B | 3.7× | – |
| EV/EBITDA | 30.6× | – |
| P/FCF | 11.6× | – |
| FCF yield | 8.6% (better) | −1.1% |
| Fair value | $16.16 | – |
| Margin of safety | −26.1% | – |
| Growth | ||
| Revenue growth (TTM) | −3.4% | 41.7% (better) |
| Revenue growth, 5Y average | – | 27.9% |
| Profitability | ||
| Gross margin | 20.0% | 65.2% (better) |
| Operating margin | 0.48% (better) | −39.4% |
| Net margin | −2.6% (better) | −37.9% |
| FCF margin | 6.3% (better) | −18.2% |
| Return on equity | −12.3% | – |
| Return on invested capital | 0.69% | – |
| Financial health | ||
| Debt / equity | 1.98 | – |
| Net debt / EBITDA | 9.12 | – |
| Interest coverage | – | −96.6× |
| Current ratio | 0.97 | 3.60 (better) |
| Altman Z-score | 0.79 | 3.69 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | 0.00% |
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 104% | 99.8% |
| Held by insiders | 3.9% | 1.8% |
| Insider net buying, 12 months | −$4.7M (better) | −$173M |
| Short interest, % of float | 9.2% | 7.2% |
Go deeper
- FTRE stock overview
- FTRE income statement
- FTRE valuation and score
- GH stock overview
- GH income statement
- GH valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.